Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Clear cell RCC"'
Autor:
Nattaradee Kiatprungvech, Premsant Sangkum, Rozita Malinee, Suchada Sommaluan, Veerawat Korkiatsakul, Suchin Worawichawong, Budsaba Rerkamnuaychoke, Adcharee Kongruang, Suraida Aeesoa, Panuwat Lertsithichai, Kittinut Kijvikai, Wisoot Kongchareonsombat, Teerapong Siriboonpiputtana
Publikováno v:
Practical Laboratory Medicine, Vol 40, Iss , Pp e00410- (2024)
Objectives: While recent studies have demonstrated several genetic alterations are associated with pathogenesis of RCC, the significance of cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase inhibitor 2B (CDKN2B) in tumorigenes
Externí odkaz:
https://doaj.org/article/e4f4459dd1594017bae6866b60ed0ba3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ahmed Alasker, Turki Rashed Alnafisah, Mohammad Alghafees, Belal Nedal Sabbah, Areez Shafqat, Abdullah Alhaider, Abdulrahman Alsayyari, Naif Althonayan, Mohammed AlOtaibi, Fisal Tariq Aldokhel, Salman Bin Ofisan, Saud Abdullah Alawad
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 10, Iss 4 (2023)
This retrospective study aims to describe the characteristics of renal cell carcinoma (RCC) in Saudi Arabia, in terms of epidemiology, clinical presentation, tumor subtype, Fuhrman grade, tumor size and stage, and overall survival. A total of 431 adu
Externí odkaz:
https://doaj.org/article/6e98710303d8482781cf2855cb1db8f1
Autor:
Taha Cetin, Serdar Celik, Sinan Sozen, Bulent Akdogan, Volkan Izol, Guven Aslan, Evren Suer, Yildirim Bayazit, Nihat Karakoyunlu, Haluk Ozen, Sumer Baltaci, Fatih Gokalp, Ilker Tinay
Publikováno v:
Archivio Italiano di Urologia e Andrologia (2023)
Objectives: To compare overall survival (OS), recurrence free survival (RFS), and cancer-specific survival (CSS) in the long-term follow-up of T1 and T2 clear-cell-Renal Cell Carcinoma (ccRCC) and papillary Renal Cell Carcinoma (pRCC) patients, as we
Externí odkaz:
https://doaj.org/article/2546a0608e3c4efbb95dce5014a0f093
Autor:
Jean Courcier, Alexandre De La Taille, Riccardo Bertolo, Daniele Amparore, Selcuk Erdem, Onder Kara, Michele Marchioni, Nicola Pavan, Eduard Roussel, Maria Mamodaly, Riccardo Campi, Alexandre Ingels
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Renal medullary carcinoma (RMC) is a rare form of renal cell carcinoma that has a poor prognosis. It is known to be associated with sickle cell trait or disease, although the exact underlying mechanisms are still unclear. The diagnosis is made throug
Externí odkaz:
https://doaj.org/article/238db8662b954bc7aaa7a435268a2977
Autor:
Dennis Gürgen, Michael Becker, Mathias Dahlmann, Susanne Flechsig, Elke Schaeffeler, Florian A. Büttner, Christian Schmees, Regina Bohnert, Jens Bedke, Matthias Schwab, Johann J. Wendler, Martin Schostak, Burkhard Jandrig, Wolfgang Walther, Jens Hoffmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient’s life. Patients with advanced, metastasized RCC have a poor prognosis. The majority of patients develop treatment resistance towar
Externí odkaz:
https://doaj.org/article/7ac4640177bd4ea9bb1cc13c5cadf092
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Medica Lituanica, Vol 27, Iss 1 (2020)
Background. Von Hippel-Lindau disease (VHL) is a rare autosomal dominant syndrome diagnosed for 1 out of 36000–45000 newborns and 90% of the patients have a clinical manifestation before 65 years of age. Affected individuals have an increased risk
Externí odkaz:
https://doaj.org/article/9baf02ea336f43a081b4bae3ab5ee804
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10362
The prognosis for patients with RCC is very poor because this cancer is diagnosed mainly in the metastatic stage and is resistant to radio- and chemotherapy. According to recent research, CacyBP/SIP exhibits phosphatase activity against MAPK and may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::96fa19290d339a8f36548c8c19e79eeb